Medical Devices Company OptoMedic Completes ￥100 million Series C Financing

According to PEdaily.cn, Guangdong OptoMedic Technologies Inc. ("OptoMedic"), a leading Chinese enterprise in the field of fluorescent navigation endoscope, announced the completion of a Series C financing of nearly 100 million yuan, with participation from Guangdong Guoke, Hetang Innovation, Morale Capital and Jiutuo Investment. Prior to this, OptoMedic had obtained the investment from THG Ventures, Fortune Venture Capital, and other well-known investment institutions.

OptoMedic is a high-tech company committed to providing high-performance medical devices and services utilizing cutting-edge optical and bio-optical technologies in the medical field.

OptoMedic was founded in July 2013 by a coalition of multidisciplinary experts in medical, biomedical, engineering, quality assurance as well as regulatory affairs. Dedicated to technological innovations, the company provides an array of high-end medical devices for its customers, among which the intraoperative endoscopic fluorescence navigation system has become a global leader and been widely used across many departments in general surgery.

OptoMedic has subsidiaries or R&D labs in Suzhou, Beijing, Changsha, Wuhan, and aspires to be at the forefront of medical technology development through multidisciplinary collaborations with renowned research and clinical institutions including Tsinghua University, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Peking University School of Pharmaceutical Sciences and tier-1 teaching hospitals in China.

In addition to the industry-leading endoscopic fluorescence navigation system, OptoMedic has also developed a number of R&D pipelines of minimally invasive surgical instruments, and is committed to becoming a comprehensive technical solution provider in minimally invasive surgical application scenarios.

Morale Capital was jointly-founded by a seasoned private equity management team and a well-established conglomerate. The company invests broadly in innovative products/solutions that fulfill the healthcare, education, and lifestyle needs of China's modern society. Leveraging its industry insights and professional value -added service, Morale Capital strives to be both partners of and companions to portfolio companies on their path to accelerated growth.